CONSTANT THERAPEUTICS
CONSTANT THERAPEUTICS logo

Constant Therapeutics LLC is a private biopharmaceutical company developing peptide and small molecule drugs that are agonists of the alternative renin angiotensin system, the protective arm of the renin angiotensin system (RAS). This protective pathway involves the enzyme ACE2, its principal product, the peptide angiotensin-(1-7), and the peptide’s targets, the Mas and MrgD receptors. Constant’s lead drug candidate is TXA127.

Disclaimer : All logos and trademarks on this website are the property of their respective owners. The information on this website is not a medical or investment related advice. The information about the company might not reflect the most current or accurate information. Please refer to the company's respective website for the most accurate information.

© 2023-24 DxMultiomics. All rights reserved.